{
    "nctId": "NCT05976815",
    "briefTitle": "Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients",
    "officialTitle": "Improving Response to Chemotherapy by Adding Physical Exercise in the Neoadjuvant Setting of Breast Cancer Patients - The KEYMOVE Randomized Controlled Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 86,
    "primaryOutcomeMeasure": "Pathologic Complete Response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. being female gender;\n2. age equals or greater than 18 years old;\n3. having a newly diagnosed histologically confirmed breast carcinoma IA-IIIC;\n4. planned to receive neoadjuvant chemotherapy with anthracyclines or taxanes, that might be associated to anti-HER2 drugs;\n5. being followed by the oncology department of the CHVNG/E;\n6. medical oncologists consents the practice of physical exercise;\n7. the patient is capable of providing written informed consent;\n8. the participant accepts to be allocated to the control or experimental group, according to the randomization.\n\nExclusion Criteria:\n\n1. previous cancer diagnostic;\n2. evidence of synchronous oncologic disease;\n3. physical or psychiatric contraindication to the practice of physical exercise.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}